Compare VCEL & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCEL | FOXX |
|---|---|---|
| Founded | 1989 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 16.9M |
| IPO Year | 1997 | N/A |
| Metric | VCEL | FOXX |
|---|---|---|
| Price | $35.60 | $3.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $57.50 | N/A |
| AVG Volume (30 Days) | ★ 592.7K | 112.3K |
| Earning Date | 11-06-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 236.54 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $258,716,999.00 | $63,030,415.00 |
| Revenue This Year | $17.86 | N/A |
| Revenue Next Year | $18.55 | N/A |
| P/E Ratio | $146.02 | ★ N/A |
| Revenue Growth | 14.05 | ★ 139.29 |
| 52 Week Low | $29.24 | $1.71 |
| 52 Week High | $63.00 | $11.00 |
| Indicator | VCEL | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 40.86 | 47.03 |
| Support Level | $35.53 | $3.42 |
| Resistance Level | $38.15 | $4.87 |
| Average True Range (ATR) | 1.26 | 0.75 |
| MACD | -0.10 | -0.09 |
| Stochastic Oscillator | 25.60 | 24.03 |
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.